As scientists unlock the human genome and map perturbation networks, there is the prospect of personalised medicine, which will have huge human and commercial implications. The Grand Duchy is turning into a specialist centre dedicated to the life sciences sector, thanks to the skill it already has in molecular diagnostics, bio-IT, medical IT, and medical devices. This initiative is part of the effort to diversify the Luxembourg economy.
The Grand Duchy has staked its claim by teaming up with two world-renowned American research institutes — the Translational Genomics Institute (TGen) and the Institute for Systems Biology (ISB) in Seattle — as well as the Phoenix-based Partnership for Personalised Medicine (PPM), working with experts from the University of Luxembourg and various public research centres on three projects:
- a biobank, the Integrated Biobank of Luxembourg (IBBL);
- a centre for systemic biology, the Luxembourg Centre for Systems Biomedicine (LCSB);
- a research cooperation into the validation of markers for lung cancer.
Backed by substantial public funding, this initiative aims at helping the country raise its profile in the global research community and increase local expertise, more particularly in the field of molecular diagnostics. In keeping with the country's traditional openness, international research projects will be able to access the biobank. The project will also benefit from the expertise in computerised data security which has been developed within the financial sector.
Other areas covered include medical and diagnostic tools. Indeed, situated at the intersection between technology and biomedicine, these sectors offer opportunities for interesting synergies with well-established research and economic activities, such as materials sciences, clinical engineering and the plastics industry. Support services, such as IT specialists, IP management and logistics, constitute a further development niche where the Grand Duchy can build on existing strengths as well as the state-of-the-art equipment of its public research centres and its university. Nonetheless, the government remains open to other opportunities that may arise in the context of either major research projects or business ventures.
Luxembourg for Business — Proud to promote science and technology, and its LetzBio portal
Luxembourg for Business — Proud to promote science and technology, with its portal at www.letzbio.lu, brings together all the stakeholders in the development and promotion of the life sciences sector.
The portal is aimed at the sector's researchers, businesses and investors, and more specifically at the international stakeholders, to encourage them to come to the Grand Duchy. By emphasising partnerships based on local know-how, particularly with the Luxembourg Centre for Systems Biomedicine (LCSB) and the Life Sciences Research Unit (LSRU) at the University of Luxembourg, the Integrated BioBank of Luxembourg (IBBL) and Luxembourg Institute of Health (LIH), the LetzBio website aims to promote all the local players specialising in the life sciences.
Luxembourg BioHealth Cluster
The Luxembourg BioHealth Cluster is a network giving support to different key players in the sector of health technologies in the Grand Duchy by helping them to develop synergies and new national and international partnerships through RDI projects.